Changes in gamma oscillations (20-50 Hz) have been observed in several neurological disorders. However, the relationship between gamma and cellular pathologies is unclear. Here, we show reduced behaviorally-driven gamma before the onset of plaque formation or cognitive decline in a mouse model of Alzheimer's disease (AD). Optogenetically driving FS-PV-interneurons at gamma (40 Hz), but not other frequencies, reduced levels of amyloid-β (A β) 1-40 and A β 1-42 isoforms.
plaque load in aged, depositing mice. Our findings uncover a previously unappreciated function of gamma rhythms in recruiting both neuronal and glial responses to attenuate AD-associated pathology.
Activation of local circuits of excitatory and fast-spiking inhibitory neurons that resonate at 20-50 Hz gives rise to oscillations in the local field potential (LFP), called gamma oscillations. [1] [2] [3] Although studies have demonstrated disrupted gamma in various neurological diseases, the interplay between pathology and this emergent circuit property has yet to be determined. 4, 5 In general, molecular and cellular pathology is thought to alter synaptic activity. However, in at least one disorder, Alzheimer's disease (AD), changes in synaptic activity can also feedback to alter molecular pathology. Studies have shown that increases in synaptic activity in vivo increase levels of amyloid-β (A β), 6 a 36-43 amino acid protein, whose aggregation is thought to initiate neurotoxic events, including neuroinflammation, synaptic and neuronal loss, and Tau-associated pathology. 7 We aimed to determine how gamma might affect molecular pathology in a mouse model of AD. Understanding how gamma may affect disease pathogenesis has important implications for elucidating both the basic pathology of and possible therapeutic interventions for neurological diseases with altered gamma.
Gamma is decreased during hippocampal sharp wave ripples in 5XFAD mice early in disease
Altered gamma has been observed in multiple brain regions in several neurological and psychiatric disorders, including a reduction in spontaneous gamma synchronization in AD patients and reduced gamma power in multiple AD mouse models. 4, 5, 8, 9 However, it is unclear if gamma is altered in other mouse models of AD, if it occurs early in disease progression, and if gamma affects disease pathology. Accordingly, we recorded neural activity from behaving 5XFAD mice, a well-established model of Alzheimer's disease. 10 In 3-month-old mice, which have elevated levels of A β but no major plaque accumulation in the hippocampus or manifestation of learning and memory deficits, 10 we recorded neural activity from hippocampal subregion CA1, where gamma has been particularly well characterized (e.g. [11] [12] [13] [14] , using a virtual environment (Ext. Data Fig. 1a ). In CA1, gamma is present during distinct periods of activity: running, when theta oscillations (4-12 Hz) occur (Ext. Data Fig. 1b, left) , and quiescent behavior, when sharp-wave ripples (SWR) occur 15, 16 (Ext. Data Fig. 1b, right) . We found no clear differences in slow gamma power (20 to 50 Hz) between 5XFAD mice and wild-type (WT) littermates during theta (Ext. Data Fig. 1c, d ).
We next examined gamma during SWRs, high frequency oscillations of 150-250 Hz lasting around 50-100 ms (Ext. Data Fig. 1b, e ). 14 Prior work has shown that slow gamma is elevated during SWRs and increased gamma synchrony across CA3 and CA1 during SWR correlates with more coordinated firing between neurons. 16 Similarly, we found increased gamma power during SWRs ( Fig. 1da yellow arrow indicates elevated gamma, Ext. Data Fig. 1e ). The instantaneous frequencies of these slower oscillations (10-50 Hz, Methods) were a unimodal distribution centered around 40 Hz (Fig. 1b, Ext. Data Fig. 1f ). Comparing gamma during SWRs in WT and 5XFAD littermates, we found that gamma power was significantly lower in 5XFAD than in WT mice (Methods, Fig. 1c , Ext. Data Fig. 1g, j ; examples in Fig. 1c, top) . Spiking was phase modulated by gamma in both groups, although the depth of modulation was significantly smaller in 5XFAD than in WT animals ( Fig. 1d , Ext. Data Fig. 1h, k) . Furthermore, there were fewer SWRs per time in non-theta periods in 5XFAD mice compared to WT (Ext. Data Fig. 1i ), reducing periods when gamma power is elevated (Fig. 1a ,c, Ext. Data Fig. 1e ). These results reveal deficits in gamma modulation of CA1 spiking in a mouse model of AD prior to the development of major amyloid plaque accumulation or evidence of cognitive impairment. This deficit in gamma converges with evidence of gamma deficits in different mouse models of AD, and reports that gamma is altered in humans with AD. 5, 8, 9 Indeed, molecular deficits in Nav1.1 in humans have been linked with gamma deficits in hAPP mice. 7
Gamma stimulation reduced A β production in hippocampal CA1
These gamma deficits during SWRs early in disease progression in this mouse model of AD prompt the question of whether gamma could affect molecular and cellular AD pathophysiology. To test this, we induced gamma optogenetically in 5XFAD/PV-Cre mice (Methods, Fig. 1e , left, Ext. Data Fig. 2a , b, c). We chose to drive FS-PV-interneurons at 40
Hz because we found deficits in gamma during SWRs, and instantaneous gamma frequencies during SWRs were centered around 40 Hz. Delivering 1 ms 473 nm light pulses at 40 Hz resulted in increased power at 40 Hz in LFPs in CA1, while random stimulation did not (Fig. 1e , Ext. Data Fig. 1l ). Both resulted in similar firing rates (Ext. Data Fig. 1m , n, o).
A β accumulation is thought to initiate multiple neurotoxic events typical for AD pathology. Therefore, we examined whether gamma stimulation affected overall A β peptide levels in the hippocampus of 5XFAD mice. We found that 1 hr of FS-PV-interneuron stimulation reduced A β 1-40 by 53.22% and A β 1-42 by 44.62% in the 40 Hz group which expresses ChR2 compared to the EYFP control group, as measured in CA1 by A β enzyme-linked immunosorbent assay (ELISA) ( Fig. 1f , g, raw concentration (pg/ml) in Ext. Data Table 1 ). We performed a comprehensive set of control experiments to determine whether the effect was specific to frequency, cell type, and/or rhythmicity. Neither stimulation of CamKIIpositive excitatory neurons at 40 Hz, nor FS-PV-interneurons at 8 Hz or random intervals significantly reduced A β levels ( Fig. 1f -i, Methods). Immunohistochemical analysis using two β-amyloid-specific antibodies (Cell Signaling Technology; D54D2, BioLegend; 12F4 17 ) in CA1 confirmed these results: A β labeling intensity was significantly reduced by 39.5% following 40 Hz stimulation compared to EYFP controls ( Fig. 2e , f, D54D2 antibody, Ext. Data Fig. 2e , f, 12F4 antibody).
Brain amyloid concentration depends on A β production from amyloid precursor protein (APP) and A β clearance rates. To elucidate how 40 Hz stimulation reduced A β production, we examined its effects on APP cleavage by measuring levels of the cleavage intermediates of APP, C-terminal fragments (CTFs) and N-terminal fragments (NTFs), in the hippocampus of the 5XFAD/PV-Cre mice. Following 40 Hz stimulation, we found significantly reduced APP CTFs and NTFs compared to EYFP and random controls ( Fig. 2a , b, c, d, Ext. Data Fig. 2d ).
Prior work has shown that APP is transported and processed in recycling endosomes 18 , and enlarged early endosomes have been observed in brain tissue from AD patients 19 . Therefore, we characterized endosomes in CA1 following stimulation using two markers, EEA1 (early endosomal antigen 1) and Rab5 (Ras-related protein encoded by the RAB5A gene).
Altogether, the intensity of endosomal labeling of CA1 neurons significantly decreased in both EEA1 (39.7%) and Rab5 (40.1%) following 40Hz stimulation compared to EYFP controls ( Fig. 2e , g, Ext. Data Fig. 2g, h) . These results suggest that in addition to observed changes in APP cleavage products, 40 Hz stimulation also alters general endosomal processing.
Gamma stimulation induced morphological transformation of microglia
To further explore the cellular and molecular effects of stimulation in an unbiased manner, we performed genome-wide RNA sequencing (RNA-seq) of CA1 tissue following 1 hr of 40 Hz or no stimulation (EYFP) of the 5XFAD/PV-Cre mice (Fig. 3a , Ext. Data Fig. 3a , b, c). Interestingly, 35% of all up-regulated genes had their highest expression in microglia ( Fig.  3b ). This RNA-seq analysis strongly suggests that 40 Hz stimulation causes an alteration in the state of microglia, which is significant given the accumulating evidence that microglia play a role in AD pathology. 20 Transcriptomic changes following 40 Hz stimulation were positively correlated with changes due to increased neural activity (by NMDA and bicuculline), and negatively correlated with changes due to silencing activity (by tetrodotoxin) (Ext. Data Fig. 3d ). The immediate early genes Nr4a1, Arc, and Npas4, which are up-regulated by neuronal activity, were elevated as shown by both RNA-seq and RT-qPCR (Ext. Data Fig. 3e ).
These transcriptomic results also suggest an engulfing state of microglia. The up-regulated genes were positively correlated with genomic changes induced by macrophage colonystimulating factor (MCSF) and granulocyte macrophage colony-stimulating factor (GMCSF), known to promote microglial A β uptake (Ext. Data Fig. 3d ). 21 RT-qPCR confirmed that up-regulated genes included microglial engulfment associated genes Cd68, B2m, Bst2, Icam1, and Lyz2 ( Fig. 3c ). Microglia-enriched transcriptional regulator Irf7, cell adhesion and migration regulator Spp1, and microglia proliferation markers Csf1r and Csf2ra were also up-regulated ( Fig. 3c ). Importantly, RT-qPCR showed that the expression levels of pro-inflammatory genes Il6, Il1b (Il1-β), Itgam (CD11-b) and an anti-inflammatory gene Igf1 were not changed ( Fig. 3c ).
Given that 40 Hz stimulation up-regulated both phagocytosis-and migration/cell adhesionrelated genes, we examined morphological features of microglia activation. We used an antibody against microglial marker Iba1 to label microglia in CA1 sections from 5XFAD/PV-Cre mice after 1 hr of 40 Hz or random stimulation, or in mice expressing only EYFP (EYFP, Fig. 3d ). We observed almost twice as many microglia in the 40 Hz group compared to EYFP and random control groups ( Fig. 3d, e ). Furthermore, microglia cell body diameter increased by 135.3% following 40 Hz stimulation compared to EYFP controls and by 138.7% compared to random stimulation ( Fig. 3d , f). The length of microglia primary processes were reduced by 54.0% in the 40 Hz stimulation condition compared to EYFP controls and by 38.5%compared to random stimulation ( Fig. 3d, g) . Iba1 levels did not affect these findings as gene expression analysis showed that Iba1 expression did not differ between conditions (Ext. Data Fig. 3a, b ). The increase in cell body size and decrease in process length observed after 40 Hz stimulation are consistent with a shift towards a phagocytic state of microglia. 22 To evaluate microglia A β uptake specifically, we measured co-localization of A β within microglia by co-immunostaining with an A β antibody (12F4, Methods). The percent of microglia co-localized with A β in the cell body increased to 85.6% following 40 Hz stimulation from 31.7% (EYFP control, Fig. 3d ,h). 3D renderings of microglia further demonstrate the presence of Aβ within microglia (Ext. Data Vid. 1, 2, 3). We did not find evidence of neuronal loss by measuring the CA1 cellular layer thickness (Ext. Data Fig. 3f, g) . Together, these results suggest that gamma stimulation triggers microglia to increase A β uptake.
Visual stimulation by light flicker drives gamma non-invasively in primary visual cortex
Many studies have shown that visual stimulation can drive oscillations in the gamma range. 2, 23 In particular, flickering lights at a specific frequency can induce that frequency in primary visual cortex (VC). 24 To determine if light flickering could entrain 40 Hz oscillations and subsequently alter A β, we exposed 5XFAD mice to 40 Hz flickering for 1 hr, analogous to optogenetic stimulation that reduced A β described above ( Fig. 4a , Ext.
Data Vid. 4). In VC, we found that light flickering at 40 Hz increased power in the LFP at 40 Hz, while random interval flickering (random flicker) and dark exposure did not ( Fig. 4a , Ext. Data Fig. 4a ). All induced similar firing rates (Ext. Data Fig. 4b, c ). Spiking increased and decreased concomitantly as the light flickered on and off, resulting in spiking entrained to 40 Hz during 40 Hz flicker but not during random flicker (Fig. 4b ). Recordings from saline above the brain exhibited no change in 40 Hz power during 40 Hz flicker, showing that this effect was not due to photoelectric effects or electrical noise (Ext. Data Fig. 4d , e).
Visual stimulation by light flicker decreases A β levels in primary visual cortex
Given that 40 Hz light flicker entrains 40 Hz oscillations in VC, we aimed to determine whether 40 Hz flicker could reduce A β levels. 3-month-old 5XFAD mice were placed in a dark box and exposed to either light flicker at different frequencies (20, 40, or 80 Hz), random flicker, constant light on (light), or dark for 1 hr. One hour after 1 hr of 40 Hz flicker, we observed that A β 1-40 levels in VC were reduced by 57.96% and Aβ 1-42 levels by 57.97% compared to dark controls (as measured by A β ELISA, Fig. 4c ). The effect was specific to 40 Hz flicker as neither constant light nor 20 Hz, 80 Hz, or random flicker significantly reduced A β levels compared to dark and light controls ( Fig. 4c ). We also found no change in A β levels in somatosensory barrel cortex and hippocampus following 40 Hz flicker (Ext. Data Fig. 5a -h). When we pretreated 5XFAD mice with a low dose GABA-A antagonist (picrotoxin, 0.18 mg/kg 25 ), the effects of 40 Hz flicker on A β levels were completely abrogated, indicating that GABAergic neurotransmission is necessary for this effect (Fig. 4c ). To demonstrate that these effects extend beyond the 5XFAD mouse, we examined the effect of 40 Hz flicker in APP/PS1 mice, another well-validated AD model, 26 and found significantly reduced Aβ 1-40 , by 20.80%, and a non-significant trend of reduced Aβ 1-42 by 37.68%(Ext. Data Fig. 6a ). Furthermore, in 9-month-old WT mice, we found a 58.2% reduction in endogenous mouse A β 1-40 following 1 hr of 40 Hz flicker (Ext. Data Fig. 6b ). The reduction of endogenous mouse A β 1-40 in WT animals reveals that these effects are not restricted to transgenic APP expression or mutant APP; rather, they extend to A β produced from endogenous APP driven by its endogenous promoter.
Next, we investigated whether 40 Hz flicker alters microglia activity in VC in a similar manner that 40 Hz optogenetic stimulation altered CA1 microglia. While microglia number was unchanged ( Fig. 4d, e ), microglia cell body diameter increased by 165.8% following 40 Hz flicker compared to dark controls ( Fig. 4d, f ). Microglia primary process lengths were reduced by 37.7% after 40 Hz flicker compared to dark controls ( Fig. 4d , g). Consistent with this morphology, which indicates enhanced engulfment activity, 22 Aβ/Iba1 co-localization in the cell body was increased to 90.8%after 40 Hz flicker from 57.3% in the dark condition, indicating more A β-bearing microglia ( Fig. 4d , h, p<0.01). To better resolve the morphological change in microglia, we used CLARITY 27 to create 3D renderings of microglia from 100 μm sections of VC, (Ext. Data Vid. 5, 6) . To demonstrate that microglia indeed engulf A β in the 5XFAD mouse, we purified microglia from 5XFAD and WT animals using fluorescence-activated cell sorting (FACS, Methods) and analyzed A β levels via ELISA. We found that microglia-specific levels of A β are significantly higher in 5XFAD animals than in WT controls (Ext. Data Fig. 7a, b ). Synaptophysin levels did not change between dark and 40 Hz flicker conditions, indicating that microglia activation likely did not affect synapse number (Ext. Data Fig. 7c, d , n.s. = not significant, n=4 mice). Thus, 40 Hz oscillations induced non-invasively via sensory entrainment reduced A β abundance and promoted microglia/A β interactions.
Chronic visual stimulation by light flicker decreases plaque load in VC
We next assessed whether 40 Hz flicker was effective to treat animals that have amyloid plaques. Because the effects of 40 Hz flicker on soluble A β levels were transient (Ext. Data Fig. 8a ), we hypothesized that we would need repeated exposure to affect insoluble A β.
Thus, we treated 6-month-old 5XFAD mice, which have amyloid plaque pathology in many brain regions including VC, 10 for 1 hr daily over 7 days with 40 Hz flicker or dark, and analyzed VC tissue 24 hr later. We found that 7 days of 1 hr 40 Hz flicker reduced both soluble A β 1-40 and A β 1-42 levels, by 60.5% and 51.7% respectively, (Fig. 4i , j) and insoluble A β 1-40 and A β 1-42 levels by 43.7% and 57.9% respectively ( Fig. 4i , j).
Immunohistochemical analysis showed that 40 Hz flicker significantly reduced plaque number in VC by 67.2% compared to dark controls ( Fig. 4k , l) and plaque size by 63.7% (Fig. 4k, m) . Taken together, these experiments identify a non-invasive treatment with a profound effect on amyloid plaque pathology. We next determined if 40 Hz flicker reduced tau phosphorylation, another AD-related pathology. Using the TauP301S tauopathy mouse model 28 we found that 7 days of 1 hr 40 Hz visual flicker treatment reduced phosphorylated tau serine202 and serine404/threonine403/serine400 levels in VC by 41.2% and 42.3%, respectively, and triggered microglia responses similar to those observed in 5XFAD mice (Ext. Data Fig. 9a -k).
Discussion
Gamma oscillations are thought to be important for higher cognitive functions and sensory responses. 2, 12, 23 Here, we demonstrated that entraining oscillations and spiking at 40 Hz, using optogenetics in the hippocampus of 5XFAD mice and using a non-invasive light flicker treatment to affect primary visual cortex in multiple mouse models, resulted in a marked reduction of A β peptides. We also found a concomitant microglia response following 40 Hz entrainment.
The robust reduction of total amyloid levels was likely mediated by both decreased amyloidogenesis and increased amyloid endocytosis by microglia. Thus, it appears that driving 40 Hz gamma oscillations may induce an overall neuroprotective response that recruits both neurons and microglia. The fact that GABA-A antagonist treatment completely abrogated the effects of 40 Hz stimulation on A β levels strongly suggests that GABAergic neurotransmission is critical for these effects. 40 Hz flicker stimulation reduced A β in multiple mouse models, including 5XFAD, APP/ PS1, and WT mice. This replication in multiple mouse models shows that these findings are not specific to one animal model and, importantly, extend to situations where A β is produced from APP expressed by its physiological promoter as it is in WT animals. In addition, we found that 40 Hz oscillations reduced phosphorylated tau in a mouse model of tauopathy, TauP301S, showing that the protective effects of gamma stimulation generalize to other pathogenic proteins. In summary, these findings uncover previously unknown cellular and molecular processes mediated by gamma oscillations and establish a functional connection between brain gamma rhythms, microglia function, and AD-related pathology.
These observations indicate that entraining gamma oscillations may provide a broad spectrum of systemic effects in the brain, including in non-neuronal cells, to attenuate Alzheimer's-related pathology. Because this approach is fundamentally different from prior AD therapies, 29 further study is needed to determine whether this approach will be therapeutic in human AD.
Methods

Animals
All animal work was approved by the Committee for Animal Care of the Division of Comparative Medicine at the Massachusetts Institute of Technology. Adult (3-month-old) male double transgenic 5XFAD Cre mice were produced by crossing 5XFAD transgenic mice with the transgenic PV or CW2 promoter driven Cre line. Adult (5-month-old) male and female APP/PS1 mice were gifted from the Tonegawa Laboratory. Adult (4-month-old) male TauP301S mice were obtained from the Jackson Laboratory. 9-month-old WT mice (C57Bl/6) were obtained from the Jackson Laboratory. Mice were housed in groups of 3-5 on a standard 12 hr light / 12 hr dark cycle, and all experiments were performed during the light cycle. Food and water were provided ad libitum unless otherwise noted. Littermates were randomly assigned to each condition by the experimenter. Experimenter was blind to animal genotypes during tissue processing and electrophysiological recording and analysis. No animals were excluded from analysis.
AAV vectors
Adeno-associated viral particles of serotype 5 were obtained from the Vector Core Facility at The University of North Carolina at Chapel Hill. The AAV5 virus contained a channelrhodopsin-2 (ChR2) fused to enhanced yellow fluorescent protein (EYFP) in a double-floxed, inverted, open-reading-frame (DIO) driven by the EF1 α promoter (Ext. Data Fig. 2a ). An AAV-DIO-EYFP construct was used as a control.
Surgical procedures
3-month-old 5XFAD/PV-Cre or CW2 mice were anesthetized with an intraperitoneal (i.p.) injection of a mixture of ketamine (1.1 mg kg -1 ) and xylazine (0.16 mg kg -1 ). A small craniotomy was made 2.0 mm posterior to bregma and 1.8 mm lateral to the midline on the left side. Virus was delivered through a small durotomy by a glass micropipette attached to a Quintessential Stereotaxic Injector (Stoelting). The glass micropipette was lowered to 1.2 mm below the brain surface. A bolus of 1 μ L of virus (AAV-DIO-ChR2-EYFP or AAV-DIO-EYFP; 2 × 10 12 viral molecules per ml) was injected into the CA1 region of hippocampus at 0.075 μ L min -1 . The pipette remained in place for 5 min following the injection before being retracted from the brain. A unilateral optical fiber implant (300 μ m core diameter; Thor Labs) was lowered to 0.9 mm below the brain surface about the injection site. Two small screws anchored at the anterior and posterior edges of the surgical site were bound with dental glue to secure the implant in place.
For electrophysiological recordings adult (3-month-old) male 5XFAD/PV-Cre and 5XFAD negative littermates (for CA1 recordings), or 5XFAD and their wild type littermates (for VC recordings) mice were anesthetized using isoflurane and placed in a stereotactic frame. The scalp was shaved, ophthalmic ointment (Puralube Vet Ointment, Dechra) was applied to the eyes, and Betadine and 70% ethanol were used to sterilize the surgical area. For CA1 recordings, a craniotomy (in mm, from bregma: -2 A/P, 1.8 M/L) was opened to deliver 1 μ L of virus to CA1 (as described above). The target craniotomy site for LFP recordings was marked on the skull (in mm, from bregma: -3.23 A/P, 0.98 M/L for CA1 and 2.8 A/P, 2.5 M/L for VC), three self-tapping screws (F000CE094, Morris Precision Screws and Parts) were attached to the skull, and a custom stainless steel headplate was affixed using dental cement (C&B Metabond, Parkell). On the day of the first recording session, a dental drill was used to open the LFP craniotomies (300-400 μ m diameter) by first thinning the skull until ∼100 μ m thick, and then using a 30 gauge needle to make a small aperture. The craniotomy was then sealed with a sterile silicone elastomer (Kwik-Sil WPI) until recording that day and in between recording sessions.
Optogenetic stimulation protocol
Two to four weeks following virus injection and implant placement (which provides time for the mice to recover and undergo behavior training for animals used for electrophysiology) and the virus to express in the neurons, CA1 neurons were optogenetically manipulated. A 200 mW 4793 nm DPSS laser was connected to a patch cord with a fiber channel/physical contact connector at each end. During the experiment, 1 mW (measured from the end of the fiber) of optical stimulation was delivered for 1 hr. For molecular and biochemical analyses, each animal received one of three stimulation protocols: 8 Hz, 40 Hz, or random stimulation (light pulses were delivered with a random interval determined by a Poisson process with an average frequency of 40 Hz). EYFP control animals received 40 Hz stimulation. For electrophysiological recordings each animal received all stimulation conditions interleaved during recordings.
Visual stimulation protocol
15 minutes prior to the experiment 5XFAD mice were treated with saline (Control) or picrotoxin (0.18 mg/kg). 25 For molecular and biochemical analyses mice were then placed in a dark chamber illuminated by a light emitting diode (LED) bulb and exposed to one of five stimulation conditions: dark, light, 20 Hz, 40 Hz, 80 Hz flicker (12.5 ms light on, 12.5 ms light off, 60 W) for 1h. For electrophysiological recordings each animal received dark, light, 40 Hz flicker, or random (light pulses were delivered with a random interval determined by a Poisson process with an average interval of 40 Hz) stimulation conditions interleaved in 10 s blocks during recordings.
Behavior training and virtual reality environment (VR) for electrophysiology
For CA1 recordings, headfixed animals ran on an 8" spherical treadmill supported by an air cushion through a virtual reality environment, as described in Harvey et al. 30 The motion of the spherical treadmill was measured by an optical mouse and fed into virtual reality software 31 , running in MATLAB (version 2013b, Mathworks). The virtual environment consisted of a linear track with two small enclosures at the ends where the animal could turn (Ext. Data Fig. 1a ). Animals were rewarded with sweetened condensed milk (diluted 1:2 in water) at each end of the track for alternating visits to each end of the track.
Animals learned to run on the virtual linear track over approximately one week. The animals were left to recover from the surgery for one week, and habituated to handling for one to two days before behavioral training began. To learn to maneuver on the treadmill and get comfortable in the testing environment, on the first two days of training the animals were placed on the spherical treadmill with the virtual reality system off and were rewarded with undiluted sweetened condensed milk. On the second day of training on the spherical treadmill, animals' food was restricted to motivate them to run. Animals were restricted to no more than 85% of their baseline weight and typically weighed over 88% of their baseline weight. From the third day until the end of training (typically 5-7 days) the animals were placed on the treadmill for increasing amounts of time (30 min to 2 hr) running in the VR linear track. Animals were rewarded with diluted (1:2) sweetened condensed milk at the end of the linear track after traversing the length of the track. Between recording sessions, animals were given refresher training sessions to maintain behavioral performance.
For VC recordings, animals ran on the spherical treadmill while exposed to dark, light, or light flickering conditions (described below in data acquisition). Prior to recordings animals learned to maneuver on the treadmill and get comfortable in the testing environment by being placed on the spherical treadmill (with the virtual reality system off) and receiving reward of undiluted sweetened condensed milk.
Electrophysiology data acquisition
For optogenetic stimulation of CA1 during recording, a 300 μ m core optical fiber was advanced through the craniotomy used to deliver virus to CA1 to a depth of 900 μ m into the brain. Light pulses that were 1 ms and 1 mW (measured from the end of the fiber) were delivered via a 473 nm DPSS (diode pumped solid state) laser (as described above).
To avoid photoelectric artifacts, neural activity was recorded with glass electrodes. LFP electrodes were pulled from borosilicate glass pipettes (Warner) on a filament-based micropipette puller (Flaming-Brown P97, Sutter Instruments), to a fine tip, which was then manually broken back to a diameter of ∼10-20 μ m and then filled with sterile saline. For CA1 recordings the LFP electrode was advanced through the LFP recording craniotomy at an angle 60 degrees posterior to the coronal plane and 45 degrees inferior to the horizontal plane until clear electrophysiological signatures of the hippocampal stratum pyramidale layer were observed (∼600-1000 μ V theta waves while the animal was running, clearly distinguishable sharp-wave ripples during immobility, and multiple spikes greater than 150 μ V, Ext. Data Fig. 1b ). For VC recordings the LFP electrode was advanced vertically through the LFP recording craniotomy to a depth of 600-900 μm and multiple spikes greater than 150 μ V were observed.
Data was acquired with a sampling rate of 20 kHz and bandpass filtered 1 Hz-1 kHz. Animals ran on the spherical treadmill or rested for prolonged periods. For optogenetic simulation sessions, data was recorded for 30 minutes before any stimulation began. Then stimulation was delivered at gamma (40 Hz), random (as described under optogenetic stimulation protocol), or theta (8 Hz) frequency for 10 s periods interleaved with 10 s baseline periods (no stimulation). In two animals, stimulation of each type or baseline was delivered for 5 min periods instead of 10 s periods. Each 30 minutes of stimulation recordings were followed by 5-30 minutes of recording with no stimulation. For visual light flicker simulation sessions, LED strip lights surrounding the animal lights were flickered at gamma (40 Hz), random (described above in Visual stimulation protocol), theta (8 Hz), or 20 Hz frequency for 10 s periods, or were on continuously for 10 s periods, interleaved with 10 s periods with lights off. A few recordings were made above the brain surface during light flicker to ensure that the lights did not create electrical or photoelectric noise during recording. Recording sessions were terminated after approximately 3-5 hr. Animals were 3-4 months old at the time of recording. Local field potential (LFP)-Recorded traces were downsampled to 2 kHz and then bandpass filtered between 1 to 300 Hz.
Analysis of electrophysiology recordings
Theta and SWR detection-Activity across the hippocampal network changes markedly when animals run or sit quietly and these changes are often referred to as different network states. These network states are clearly distinguishable by the presence or absence of LFP oscillations in different frequency bands 12, 13 . When animals ran, we observed large theta (4-12 Hz) oscillations in CA1 as others have shown (Ext. Data Fig. 1b, left) 13, 30, 32, 33 . When animals sat quietly, theta oscillations were no longer visible and we recorded sharp wave ripples (SWRs), high frequency oscillations of 150-250 Hz that last around 50-100 ms and are associated with bursts of population activity, as others have observed (Ext. Data Fig. 1b , right) 15, 16 .
SWRs were detected ( Fig. 1a, b , c, d, Ext. Data Fig. 1d , e, f, g, h, i) when the envelope amplitude of the filtered trace was greater than four standard deviations above the mean for at least 15 ms. The envelope amplitude was calculated by taking the absolute value of the Hilbert transform of the filtered LFP. We also confirmed our results held when using a higher threshold for SWR detection, 6 standard deviations above the mean, which detects larger SWRs (Ext. Data Fig 1j, k) . To detect theta (Ext. Data Fig. 1c,d ), the LFP was bandpass filtered for theta (4-12 Hz), delta (1-4 Hz), and beta (12-30 Hz) using an FIR equiripple filter. The ratio of theta to delta and beta ("theta ratio") was computed as the theta envelope amplitude divided by the sum of the delta and beta envelope amplitudes. Theta periods were classified as such when the theta ratio was greater than one standard deviation above mean for at least two seconds and the ratio reached a peak of at least two standard deviations above mean. Non-theta periods were classified as such when the theta ratio was less than one for at least two seconds. Sharp wave ripples, theta periods, and non-theta periods were visually inspected to ensure that these criteria accurately detected sharp wave ripple, theta periods, and non-theta periods, respectively.
Power spectrum-Spectral analysis was performing using multitaper methods (Chronux toolbox, time-bandwidth product = 3, number of tapers = 5). For examining power spectra without stimulation (Ext. Data Fig. 1c, d) , only theta periods were included: theta periods greater than 5 s long were divided into 5 s trials and the average power spectral density was computed for each animal over these trials. For examining power spectra during optogenetic (Fig. 1e , Ext. Data Fig. 1l ) and visual stimulation (Fig. 4a , Ext. Data Fig. 4a ), data was divided into 10 s trials of each stimulation condition or baseline periods, and the average power spectral density was computed for each animal over these trials.
Gamma during SWRs-Spectrograms were computed using multitaper methods (Chronux toolbox). The spectrogram was computed for each SWR including a window of 400 ms before and after the peak of the SWR. Then a z-scored spectrogram was computed in each frequency band using the mean and standard deviation of the spectrogram computed across the entire recording session to create a normalized measure of power in units of standard deviation (Fig. 1a , Ext. Data Fig. 1e ). Instantaneous frequency of gamma during SWRs was computed by bandpass filtering the LFP for 10-50 Hz, taking the Hilbert transform, then taking the reciprocal of the difference in peaks of the transformed signal ( Fig. 1b, Ext. Data Fig. 1f ). Gamma power before, during, and after SWRs was computed by filtering the LFP for low gamma (20-50 Hz) and taking the amplitude of the envelope of the Hilbert transform to get the mean gamma power in 100 ms bins centered on the SWR peak. This was normalized by the mean and standard deviation of the amplitude of the envelope for the entire recording session to get z-scored gamma power for each bin around each SWR (Fig. 1c, Ext. Data Fig. 1g, j) . Phase modulation by gamma during SWRs was computed by bandpass filtering the LFP for gamma , taking the Hilbert transform, and determining the phase of the resulting signal for each spike that occurred during SWRs (Ext. Data Fig. 1h ). To measure differences in phase modulation between 5XFAD and WT animals, we used resampling with replacement: a subset of 100 spikes from each recording was randomly selected to create a phase modulation distribution and this was repeated 500 times for each recording (Fig. 1d, Ext. Data Fig. 1k ). We then measured the depth of modulation for the spike-gamma phase distribution by computing the difference between the peak and trough divided by the sum of the peak and trough for each distribution (Fig. 1d , Ext. Data Fig. 1k ).
Differences in firing during stimulation-To plot stimulus-evoked multiunit firing histograms, spikes were binned in 2.5 ms bins for 100 ms after the start of each light on pulse and the fraction of spikes in each bin was computed. Mean and standard error was then computed across all light-on periods. To compute differences in multi-unit firing rate between conditions, firing rates were computed for each 10 s period of stimulation or baseline (total number of spikes divided by duration of period). Differences in firing rate were taken between nearby periods of the relevant type of stimulation (firing rate in gamma stimulation period minus baseline or random periods for optogenetic stimulation, firing rate in gamma stimulation period minus baseline, continuous on, or random periods for light flicker stimulation). Differences from all animals were plotted in histograms (Ext. Data Fig.  1m, 4c ) and the median and quartiles of the multiunit firing rates per 40 Hz stimulation, random stimulation, and no stimulation period for each animal were plotted in box plots (Ext. Data Fig. 1o, 4d ).
Immunohistochemistry-Mice were perfused with 4% paraformaldehyde under deep anesthesia, and the brains were post-fixed overnight in 4% paraformaldehyde. Brains were sectioned at 40 μ m using a vibratome (Leica). Sections were permeabilized and blocked in PBS containing 0.2% Triton X-100 and 10% normal donkey serum at room temperature for 1 hr. Sections were incubated overnight at 4 °C in primary antibody in PBS with 0.2% Triton X-100 and 10% normal donkey serum. Primary antibodies were anti-EEA1 (BD Transduction Laboratories; 641057), anti-β-amyloid (Cell Signaling Technology; D54D2), anti-Iba1 (Wako Chemicals; 019-19741), anti-parvalbumin (Abcam; ab32895), anti-Rab5 (Enzo Life Sciences; ADI-KAP-GP006-E). To confirm ELISA experiments, the anti-A β antibody D54D2 was used because it allowed for co-labeling with EEA1 and the anti A β antibody 12F4 was used because it does not react with APP allowing us to determine if our labeling was specific to A β. 
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Author Manuscript microscope (LSM 710; Zeiss) with a 40X objective at identical settings for all conditions. Images were quantified using ImageJ 1.42q by an experimenter blind to treatment groups. For each experimental condition, 2 coronal sections from at least 3 animals were used for quantification. Scale bars are 50 μ m. For CA1 imaging, the analysis was restricted to the pyramidal cell layer, except in the case of Iba1+ cells analysis, where the whole field of view was required to image an adequate number of cells. ImageJ was used to measure the diameter of Iba1+ cell bodies and to trace the processes for length measurement. In addition, the Coloc2 plugin was used to measure co-localization of Iba1 and Aβ. Imarisx64 8.1.2 (Bitplane, Zurich, Switzerland) was used for 3D rendering. For counting the "plaque number," deposits ≥10 μ m were included.
Clarity-Fixed brains were sliced into 100uM coronal sections on a vibratome (Leica VT100S) in 1XPBS. Sections containing VC were selected, with reference to the Allen Mouse Brain Atlas, and incubated in clearing buffer (pH 8. Western blot-CA1 whole cell lysates were prepared using tissue from 3-month-old male 5XFAD/PV-Cre mice. Tissue was homogenized in 1 ml RIPA (50 mM Tris HCl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) buffer with a hand homogenizer (Sigma), incubated on ice for 15 min, and rotated at 4 °C for 30 min. Cell debris was isolated and discarded by centrifugation at 14,000 rpm for 10 minutes. Lysates were quantitated using a nanodrop and 25 μg protein was loaded on a 10% acrylamide gels. Protein was transferred from acrylamide gels to PVDF membranes (Invitrogen) at 100 V for 120 min. Membranes were blocked using bovine serum albumin (5% w/v) diluted in TBS:Tween. Membranes were incubated in primary antibodies overnight at 4 °C and secondary antibodies at room temperature for 90 minutes. Primary antibodies were anti-APP (Invitrogen; PAD CT695), anti-APP (Sigma;A8967), anti-β-actin (Abcam; ab9485). Secondary antibodies were horseradish peroxidase-linked (GE Healthcare). Signal intensities were quantified using ImageJ 1.46a and normalized to values of β-actin. We examined tau protein solubility using sequential protein extraction as described in Yoshiyama et al., 2007. 28 We then probed the detergent insoluble tau fraction using an antibody against Tau5 (Thermo Fisher Scientific; AHB0042).
Elisa-CA1 or VC was isolated from male mice, lysed with PBS or 5M Guanidine HCl, and subjected to A β measurement with the use of mouse (for WT experiments) or human (for all other experiments) A β 1-40 or Aβ 1-42 ELISA kit (Invitrogen) according to the manufacturer's instructions. We lysed the tissue in phosphate-buffered saline (PBS) to extract the PBS soluble A β fraction. The soluble A β fraction likely contained monomeric and oligomeric A β. Tissue was further treated with guanidine HCl to extract the insoluble A β fraction. Aβ 1-42 was below detectable levels for both flicker and control groups in WT VC and microglia-specific samples.
Genome-Wide RNA Sequencing-Total RNA was extracted from CA1 isolates using the RNeasy kit (Qiagen). Purified mRNA was used for RNA-seq library preparation using the BIOO NEXTflex™ kit (BIOO# 5138-08) per the manufacturer's instructions. 1 μg of total mRNA was subject to a sequential workflow of poly-A purification, fragmentation, 1 st strand and 2 nd strand synthesis, DNA end-adenylation, and adapter ligation. The libraries were enriched by 15 cycles of PCR reactions and cleaned with Agencourt AMPure XP magnetic beads (Beckman Coulter). The quality of the libraries was assessed using an Advanced Analytical-fragment Analyzer. The bar-coded libraries were equally mixed for sequencing in a single lane on the Illumina HiSeq 2000 platform at the MIT BioMicro Center. The raw fastq data of 50-bp single-end sequencing reads were aligned to the mouse mm9 reference genome using TopHat2.0. The mapped reads were processed by Cufflinks 2.2 with UCSC mm9 reference gene annotation to estimate transcript abundances, and test for differential expression. An average of 26,518,345 sequencing reads was obtained from 3 stimulated and 3 non-stimulated mice. Relative abundance of transcript was measured by Fragments Per Kilobase of exon per Million fragments mapped (FPKM). Gene differential expression test between treated and untreated groups was performed using Cuffdiff module with an adjusted p-value<0.05 for statistical significance (GEO accession: GSE77471).
To understand the cellular and molecular mechanisms from our RNA-seq data, 14 of publicly available RNA-seq datasets 34 were processed for cell-type specific analysis. Additionally, 60 publicly available neuron-, microglia-, and macrophage-specific RNA-seq datasets under different chemical and genetic perturbations [35] [36] [37] [38] [39] [40] were downloaded and processed using TopHat/Cufflinks pipeline for gene set enrichment (GSEA) statistical analysis. GSEA was used to determine whether a defined gene set from our RNA-seq data is significantly enriched at either direction of a ranked gene list from a particular perturbation study. Genes detected in the public RNA-seq datasets were ranked by log2 values of fold change (case versus control), from positive to negative values. A defined gene set (in our case, up-or down-regulated genes upon gamma treatment) was considered significantly correlated with a perturbation-induced transcriptomic change (either up-or downregulation), when both nominal p-value and false discovery rate (FDR) q-value were less than 0.05. The sign of the calculated normalized enrichment score (NES) indicates whether the gene set is enriched at the top or the bottom of the ranked list. The heatmap for differentially expressed genes was generated using a custom R script, and z-score values across all libraries for each gene were calculated based on the gene FPKM values. The box plots for cell-type specificity analysis were also generated by R program, based on gene FPKM values.
Quantitative RT-PCR-The CA1 subregion was isolated from hippocampus of 3-monthold male 5XFAD/PV-Cre mice. Tissue was rapidly frozen using liquid nitrogen and stored at -80 °C, and RNA extracted using the RNeasy kit according to the manufacturer's protocol (Qiagen). RNA ( Data Fig. 6a ).
Code Availability-Code is publically available upon request from the corresponding author.
Statistics-For electrophysiological data that was not normally distributed, results are presented as medians and quartiles unless otherwise noted. Two-sided Wilcoxon rank sum tests for equal medians were performed to determine if distributions were significantly different, and Wilcoxon signed rank tests were performed to determine if distributions were significantly different from zero as these do not assume data is normally distributed.
Variability was similar between the groups that were statistically compared. The Bonferroni method was used to correct for multiple comparisons. No statistical method was used to estimate sample size, but it is consistent with previous publications.
Molecular and biochemical results are presented as mean +SEM. Percentages stated in manuscript are group means. All statistical analysis was performed using Prism GraphPad software. Normality was determined using the D'Agostino & Pearson omnibus normality test. Variability was similar between the groups that were statistically compared. Comparison data for normally distributed data consisting of two groups was analyzed by two-tailed unpaired t tests. Comparison of data for normally distributed data consisting of three or more groups was analyzed by one-way ANOVA followed by Tukey's multiple comparisons test. Comparison data for non-normally distributed data was carried out using Mann Whitney tests. The statistical test, exact P values, and sample size (n) for each experiment is specified in the figure legend. For optogenetic ELISA data, two-sided unpaired Student's t-tests were performed to compare mice from the same litter that received different conditions. No statistical method was used to estimate sample size, but is consistent with previous publications. Molecular and biochemical analysis was performed using a minimum of three biological replicates per condition.
Data availability-Data is publically available upon request from the corresponding author. 
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Extended Data Figure 1 . 5XFAD mice have reduced power in gamma during hippocampal SWRs b) Mouse in virtual reality environment. c) Local field potential recorded in CA1, above, filtered for theta (left) or sharp wave ripples (right), middle, and gamma, below. d) Mean and standard deviation of the normalized power spectrum during theta. Each animal's power spectral density was normalized to its peak (n=6 mice per group). e) Normalized power spectral densities during theta periods in 3-month-old 5XFAD (green, n=6 mice) and WT (black/grey, n=6 mice) mice. Each animal's power spectral density was normalized to its peak (in theta). f) Average SWR-triggered spectrograms for one WT and one 5XFAD mouse shows an increase in the gamma band during SWRs. This increase is lower in the 5XFAD mouse than in the WT mouse (n=370 and 514 SWRs in WT and 5XFAD, respectively; WT mouse shown here is the same as in Fig. 1a (ranksum tests for each animal, 3 WT and 4  5XFAD mice, p's>0.09, n=87, 130, 8, 65, 93, 91, 73 40 Hz stimulation periods and 85, 129,  5 , 64, 93, 90, 72 random stimulation periods per animal). We also examined whether 40 Hz stimulation caused neuronal hyperactivity relative to no stimulation, because according to a recent report, this could have negative effects on neural circuit function. 26 In most animals the firing rates between 40 Hz or random stimulation and no stimulation were not significantly different (ranksum tests for each animal, 2 WT and 2 5XFAD, p's>0.25, n=8, 93, 91, 73 40 Hz stimulation periods and 15, 277, 270, 215 baseline periods per animal) or the firing rates during 40 Hz or random stimulation were lower than during no stimulation (ranksum tests for each animal, 1 WT and 1 5XFAD, p's<10 -5 , which is significant when corrected for performing multiple comparisons, n=130, 65 40 Hz stimulation periods and 379, 187 baseline periods per animal) indicating that 40 Hz stimulation did not cause neuronal hyperactivity. In one animal there was significantly more activity with 40 Hz or random stimulation than during baseline (ranksum test for 1 5XFAD, mouse, p<10 -5 , n=87 40 Hz stimulation periods and 251 baseline periods per animal). Therefore in six out of seven animals we see no evidence that the 40 Hz optogenetic stimulation of FS-PVinterneurons causes hyperactivity. recording sessions in 2 5XFAD and 3 WT mice undergoing hippocampal recordings). Mean (solid line) and standard deviation (shaded area) across recordings are shown on the left and per animal on the right. Recordings with less than 3 flicker periods (light red) resulted in noisier power spectral densities than recordings with more data (dark red) but none showed evidence of peaks at 40 Hz. Extended Data Table 1 Raw A β 1-40 and A β 1-42 concentrations
Table displaying raw A β 1-40 and A β 1-42 levels with ELISA dilution ratios for each experimental group. Equal tissue masses were compared for each ELISA experiment. For 7day experiments, values were normalized to within litter controls such that raw values 1-4 in each condition were normalized to the mean of "Dark" values 1-4; raw values 5-9 in each condition were normalized to the mean of "Dark" values 5-9; raw values 10-13 in each condition were normalized to the mean of "Dark" values 10-13. 
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